PBH

PRESTIGE CONSMR HEALTHCARE I

PBH·74112D101·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

PBH (PRESTIGE CONSMR HEALTHCARE I) is held by 155 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($370.2M), ARIEL INVESTMENTS, LLC ($230.1M), VANGUARD PORTFOLIO MANAGEMENT LLC ($133.6M). Net institutional sentiment: Mixed.

155
Holders
(12 Elite)
$2.3B
Total Value
44% (162)
Consensus
72 buying - 90 selling
13F: Insider & Congress: Updated regularly
PBH

Smart Money Verdict

View all
Loading verdict
Held by 155 funds
12 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 12, 2026 · Activists Jul 7, 2026 · Congress none

ActivistAriel Investments, LLCAriel Investments, LLC10.3%Jul 7, 2026
InsiderZJZerillo JeffreySell $18KMay 11, 2026
InsiderLMLombardi Ronald M.Tax 3K shMay 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.8M(+6.0%)$370.2M0.0%-30.55%
33
Increased
4.9M(+13.9%)$230.1M2.3%-10.62%
60
Increased
2.8M(+0.8%)$133.6M0.0%-23.77%
30
Decreased
2.7M(-0.4%)$125.8M0.0%-15.72%
0
New
2.3M$110.2M0.3%+11.00%
50
Increased
2.1M(+2.1%)$101M0.0%-23.46%
31
Increased
2.1M(+7.4%)$100M0.0%-13.65%
32
Increased
2.1M(+140.1%)$97M0.7%-3.36%
68
Decreased
1.9M(-15.0%)$88.5M0.3%-30.88%
0
Increased
1.6M(+7.7%)$74.3M0.0%+5.32%
32
Decreased
1.3M(-18.4%)$61.3M0.1%-18.80%
0
Decreased
1.2M(-8.4%)$58.8M0.0%-23.45%
0
Increased
828,628(+38.3%)$39.3M0.0%-8.43%
38
Increased
773,449(+3.1%)$36.6M0.0%+27.27%
30
Decreased
750,445(-33.0%)$35.5M0.3%-17.23%
0
Increased
658,659(+39.2%)$31.1M0.0%+15.61%
38
Decreased
654,174(-11.8%)$30.9M0.0%+11.20%
0
Increased
638,605(+62.8%)$30.2M0.0%-16.44%
42
Increased
629,836(+5.3%)$29.8M0.0%+28.50%
30
Decreased
609,949(-5.2%)$28.8M0.2%-28.28%
0

Showing 1-20 of 175

1 / 9
PBHPBHPRESTIGE CONSMR HEALTHCARE I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used